Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference31 articles.
1. Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion;Masquelier;J. Med. Chem.,1980
2. Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo;Baurain;J. Med. Chem.,1980
3. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate;Trouet;Proc. Natl. Acad. Sci.,1982
4. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis;Mueller;Curr. Topics in Microbiol. & Immunol.,1996
5. Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours;Yoshii;Arch. Dermatol. Res.,1995
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Causal relationship between genetically determined plasma metabolites and skin cancer: a two-sample Mendelian randomization study;Archives of Dermatological Research;2024-05-24
2. UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies;Molecules;2024-02-08
3. Cathepsin B as a target in cancer therapy and imaging;New Journal of Chemistry;2022
4. Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo;Molecular Cancer Therapeutics;2021-03-30
5. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy;International Journal of Molecular Sciences;2021-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3